Cargando…
Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era
Autores principales: | Griffiths, W., Frew, J.A., Chandler, R., Jiang, X.Y., Pedley, I.D., Pearson, R.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Radiologists. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610090/ https://www.ncbi.nlm.nih.gov/pubmed/33158724 http://dx.doi.org/10.1016/j.clon.2020.10.012 |
Ejemplares similares
-
MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation
por: Benitez, Cecil M., et al.
Publicado: (2023) -
Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
por: Wolf, Frank, et al.
Publicado: (2020) -
Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients
por: Ishiyama, Hiromichi, et al.
Publicado: (2021) -
Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2021) -
Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer
por: Mohajer, Jonathan, et al.
Publicado: (2020)